Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia

Clinical Microbiology and Infection

Volumn 18, Issue 9, 2012, Pages 862-869

  Bassetti, M ^a   Trecarichi, E M ^b   Mesini, A ^a   Spanu, T ^b   Giacobbe, D R ^a   Rossi, M ^b   Shenone, E ^a   Pascale, G D ^b   Molinari, M P ^c   Cauda, R ^b   Viscoli, C ^a   Tumbarello, M ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Healthcare associated; Methicillin resistance; Mortality; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; DAPTOMYCIN; LINEZOLID; QUINUPRAMINE; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; EPIDEMIC; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SEPTIC SHOCK; SOLID TUMOR;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84865285121     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03679.x     Document Type: Article

References (31)

1. Benfield T, Espersen F, Frimodt-Møller N et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-263.
2. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteraemias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996; 23: 255-259.
3. Hawkins C, Huang J, Noskin GA, Zembower TR, Bolon M. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Arch Int Med 2007; 167: 1861-1867.
4. Chang FY, MacDonald BB, Peacock JE Jr et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003; 82: 322-332.
5. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28: 273-279.
6. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174.
7. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
8. de Kraker ME, Wolkewitz M, Davey PG, Grundmann H, BURDEN Study Group. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011; 55: 1598-1605.
9. Lambert ML, Suetens C, Savey A et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11: 30-38.
10. Huskins WC, Goldmann DA. Controlling methicillin-resistant Staphylococcus aureus, a 'Superbug'. Lancet 2005; 365: 273-275.
11. Charlson ME, Pompei P, Ales K, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
12. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
13. European Centre for Disease Prevention and Control (ECDC) network: HEALTHCARE-ASSOCIATED INFECTIONS. Available at: http://ecdc.europa.eu/en/activities/surveillance/HAI/Documents/2008_HAI_%20special_chapter.pdf (last accessed 8 September 2011).
14. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8thedn. Approved standard. Document M7-A8. Wayne, PA: CLSI; 2009.
15. European Antimicrobial Resistance Surveillance Network (EARS-Net). EARSS Annual Report 2008. Jan 2008.
16. Rosenthal V, Maki DG, Salomao R et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006; 145: 582-591.
17. Naimi TS, LeDell KH, Boxrud DJ et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001; 33: 990-996.
18. Rodríguez-Baño J, López-Prieto MD, Portillo MM et al. Epidemiology and clinical features of community-acquired, healthcare associated and nosocomial bloodstream infections in tertiary and community hospitals. Clin Microbiol Infect 2009; 15: 1111-1118.
19. Fatkenheuer G, Preuss M, Salzberger B et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 157-162.
20. Kaech C, Elzi L, Sendi P et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006; 12: 345-352.
21. Soriano A, Martinez JA, Mensa J et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30: 368-373.
22. Kim SH, Park WB, Lee KD et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003; 37: 794-799.
23. Kang CI, Song JH, Chung DR et al. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 2010; 61: 299-306.
24. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
25. Gomez J, Garci{dotless}a-Vazquez E, Banos R et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 2007; 26: 239-245.
26. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 2006; 34: 2069-2074.
27. Paul M, Kariv G, Goldberg E et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010; 65: 2658-2665.
28. Hope R, Livermore DM, Brick G, Lillie M, Reynolds R, BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62 (suppl 2): ii65-ii72.
29. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007; 39: 6-13.
30. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-4.
31. Manzur A, Dominguez MA, Ruiz de Gopegui E et al. Natural history of methicillin-resistant Staphylococcus aureus colonisation among residents in community long term care facilities in Spain. J Hosp Infect 2010; 76: 215-219.